SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-213106
Filing Date
2020-08-07
Accepted
2020-08-07 16:56:09
Documents
15
Period of Report
2020-08-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d930362d8k.htm   iXBRL 8-K 34965
2 EX-99.1 d930362dex991.htm EX-99.1 11923
3 EX-99.2 d930362dex992.htm EX-99.2 16096
7 GRAPHIC g930362g0807132058363.jpg GRAPHIC 2385
  Complete submission text file 0001193125-20-213106.txt   205136

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eidx-20200806.xsd EX-101.SCH 3054
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eidx-20200806_lab.xml EX-101.LAB 18887
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eidx-20200806_pre.xml EX-101.PRE 11849
8 EXTRACTED XBRL INSTANCE DOCUMENT d930362d8k_htm.xml XML 3455
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38533 | Film No.: 201085482
SIC: 2834 Pharmaceutical Preparations